Scientific data is crucially important in the fight against the pandemic - for the whole world, for Germany and for Rhineland-Palatinate. The Gutenberg COVID-19 study is intended to contribute to this by collecting population-based data in the Mainz-Bingen area for the first time. Consequently, this will allow for conclusions about the pandemic situation in Rhineland-Palatinate to become available.
The Gutenberg COVID-19 Study not only investigates the direct effects of a potential SARS-CoV-2 infection and the COVID-19 disease, but also the comprehensive effects of the pandemic and of the measures to fight the pandemic on the health of the population.
The study is funded by the European Regional Development Fund (ERDF), the ReALity Initiative of the Life Sciences of the Johannes Gutenberg University Mainz and the National Research Network of University Medicine.
First data from the Gutenberg COVID-19 study will be shown in the dashboard and updated regularly with current data.
Here you can see...
...how many people probably want to be vaccinated
...how the examined participants currently feel in terms of their mental state compared to the time before the pandemic
...how common COVID-19 specific symptoms are
...and many more data about the pandemic
Further comprehensive scientific analyses, such as on the primary endpoint of the study (proportion of positive antibody blood tests in the population), consideration of subgroups and relational associations will be conducted after inclusion of all participants and subsequently after completion of the follow-up visits.
As of now, participants who had their first examination from October on will be reinvited to the study center in downtown Mainz. The follow-up examination includes another survey using a questionnaire and an interview in the study center as well as the collection of biosamples. The surveys take current developments into account, such as the vaccination against COVID-19.